BiOptix Diagnostics, Inc.

Diagnostic Instruments: Label-free Biodetectors and Bionanoslides

Production of label-free biodetectors and, in Russia, production of disposable bionanoslides, both developed by American company BiOptix Diagnostics, Inc.

BiOptix Diagnostics, Inc., in collaboration with 2005 Nobel Prize laureate in physics John Hall, has developed a unique technology for biodetection. The biodetectors developed by BiOptix provide extremely sensitive label-free biomolecule interaction analysis in real time. This kind of measurements is essential for development of promising molecular candidates for innovation drugs.

The BiOptix biodetector does not require florescent or isotope labeling of biomolecules. This saves time and reagents and, more importantly, facilitates study that was previously unachievable.

Areas of application

• Molecular diagnostics

Market

• Pharmaceutical companies
• Scientific research institutes and universities

Competitive advantages

• Low acquisition and use costs
• Compactness
• Simplicity of use
• Reliability